نتایج جستجو برای: tolerability

تعداد نتایج: 14041  

2016
Eiji Harada Osamu Shirakawa Yoichi Satoi Lauren B Marangell Rodrigo Escobar

PURPOSE We sought to better understand how dose and titration with duloxetine treatment may impact tolerability and treatment discontinuation in patients with major depressive disorder. PATIENTS AND METHODS We investigated Phase III duloxetine trials. Group 1 was a single placebo-controlled study with a 20 mg initial dose and a slow titration to 40 and 60 mg. Group 2 was a single study with a...

Journal: :Indian journal of physiology and pharmacology 2013
B Medhi N Mittal D Bansal A Prakash S C Sarangi B Nirthi

To examine the efficacy, safety and tolerability of tolterodine in children with overactive bladder in comparison with standard treatment i.e. oxybutynin as demonstrated in randomized clinical trials and other studies. A systematic search was done to screen the studies evaluating the effect of tolterodine in children with non-neurogenic overactive bladder. Results of studies were pooled and com...

Journal: :Cutis 2021

Reports of brodalumab use for psoriasis in organ transplant recipients are limited. We report a case which was used to treat patient who had undergone solid transplantation with excellent response and good tolerability.

Journal: :Clinical and experimental rheumatology 2002
F McKenna L Arguelles T Burke J Lefkowith G S Geis

OBJECTIVE To compare the upper gastrointestinal (UGI) tolerability of celecoxib (a cyclooxygenase-2 specific inhibitor) and diclofenac using data from three randomised, double-blind clinical trials in osteoarthritis (OA) and rheumatoid arthritis (RA). METHODS Patients in two OA studies received either celecoxib 100 mg BID (n = 545), diclofenac 50 mg BID or TID (n = 540), or placebo (n = 200) ...

Journal: :Vascular Health and Risk Management 2008
Bernard Waeber Jean-Jacques Mourad

A score system integrating the evolution of efficacy and tolerability over time was applied to a subpopulation of the STRATHE trial, a trial performed according to a parallel group design, with a double-blind, random allocation to either a fixed-dose combination strategy (perindopril/indapamide 2 mg/0.625 mg, with the possibility to increase the dose to 3 mg/0.935 mg, and 4 mg/1.250 mg if neede...

Journal: :The Journal of infectious diseases 2016
Nicoline A T van der Maas T Woudenberg S J M Hahné H E de Melker

BACKGROUND In 2013-2014, a measles outbreak spread through the Netherlands. To protect young infants, measles-mumps-rubella (MMR) vaccination was offered to those aged 6-14 months in municipalities with routine first-dose MMR vaccine coverage of <90%. We assessed the tolerability of this early administration of MMR vaccine. METHODS After study entry (n = 1866), parents of eligible infants (n ...

Journal: :Seizure 2015
N. Lang W. Esser S. Evers C. Kellinghaus A. Nguento U. Schlegel B. Gaida J. Gburek-Augustat D. M. Altenmüller L. Burghaus F. Hoffmann B. Fiedler T. Bast T. Rehfeld S. Happe R. J. Seitz R. Boor U. Stephani

PURPOSE Most common clinical studies with antiepileptic drugs do not reflect medical everyday practice due to their strict in- and exclusion criteria and specifications of treatment regimens. Here we present a large non-interventional registry with the intention to evaluate the spectrum of applications in daily use and the efficacy and tolerability of intravenously given levetiracetam (LEV-iv)....

Journal: :American Journal of Geriatric Psychiatry 2023

IntroductionTreatment-resistant depression (TRD) is a serious and debilitating psychiatric disorder that frequently affects older patients. Esketamine nasal spray (ESK-NS) has recently been approved as treatment for TRD, with multiple studies establishing its efficacy tolerability. However, the real-world effectiveness, tolerability, safety of this in adults still unclear.ObjectivesTo evaluate ...

2017
Jussi Mäkinen Sirpa Rainesalo Jukka Peltola

OBJECTIVES There is limited clinical evidence for comparison between oxcarbazepine (OXC) and eslicarbazepine acetate (ESL) in terms of tolerability, or how to execute the change from OXC to ESL. We report the process of transitioning patients with focal epilepsy from previous OXC treatment to ESL due to tolerability problems. The rationale for change from OXC is reported, and the outcome with r...

2017
Rainer Reiber Hendrik Wolf Jörg Schnitker Eike Wüstenberg

BACKGROUND For causal treatment by allergy immunotherapy (AIT) a single or few allergen products for the clinically most relevant allergens are applied to treat multiple allergies, but few data on the tolerability of multiple AIT applications are available. OBJECTIVE The aim of our study was to investigate safety and tolerability in patients treated by subcutaneous immunotherapy (SCIT) and co...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید